Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Jim Miller

Articles

This second annual survey tracks teh growth of the outsourcing services sector in the past year.

Survey Finds Outsourcing Practice Continuing to Mature

The DSM investment puts biomanufacturing capacity in the spotlight. Contract biomanufacturers are adding new capacity and sponsors are marketing their excess capacity.

Capacity Worries Fade for Biomanufacturing

Gene Logic acquires TherImmune Research Corp. as part of its plan to create a new business model; First quarter results are a mixed bag for contract services companies.

Outsourcing Outlook

The successful auction of Quintiles raises questions for the company's new owners, Pharma Services Holdings, Inc., and the entire pharmaceutical industry with regard to strategic investments, assets to be sold, and other concerns.

As demand for contract services slows down, contractors restructure themselves and the industry.

CROs and CMOs project strong business operation in 2003, and contract sterile manufacturing companies invest millions to increase capacity.